I now have comprehensive content and all three key diagrams. Let me compile the full pathophysiology explanation.
Pathophysiology of Preeclampsia: Placental and Endothelial Dysfunction
Preeclampsia is fundamentally a two-stage disease: an early placental stage (poor implantation/ischemia) that triggers a second systemic stage (maternal endothelial dysfunction) responsible for all the clinical manifestations.
Stage 1 - Failure of Spiral Artery Remodeling (The Placental Stage)
In a normal pregnancy, fetal extravillous cytotrophoblasts invade the maternal decidua and the decidual spiral arteries. They destroy the vascular smooth muscle and replace maternal endothelial cells with fetal trophoblastic cells - a process called endovascular invasion. The result is conversion of spiral arteries from narrow, high-resistance vessels into wide, low-resistance, high-capacitance uteroplacental vessels that carry blood at low velocity and pressure, allowing optimal oxygen exchange.
In preeclampsia (bottom), the spiral arteries retain their smooth muscle coat, remain narrow and high-resistance, and trophoblast invasion is shallow - confined to the decidua only, not penetrating the myometrium.
In preeclampsia, this remodeling fails. Trophoblast invasion is abnormally shallow - the spiral arteries retain their smooth muscle coat and remain narrow, high-resistance vessels. Consequences:
- Reduced uteroplacental perfusion
- Placental ischemia and hypoxia - evidenced by expression of hypoxia-inducible factor 1-alpha (HIF-1α) in preeclamptic placentas
- Oxidative stress, NF-κB activation, increased necrotic trophoblast shedding, and proinflammatory interleukin production
- Pathologic inflammation - acute atherosis seen in 10% of preeclamptic placentas (lipid deposition in spiral artery intima)
(Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 954; Comprehensive Clinical Nephrology 7e, p. 627)
Stage 2 - Angiogenic Imbalance and Systemic Endothelial Dysfunction
The ischemic placenta responds by releasing anti-angiogenic factors into the maternal circulation, causing widespread endothelial injury.
The Two Key Anti-Angiogenic Proteins
1. sFlt-1 (Soluble FMS-like Tyrosine Kinase-1)
- A truncated, soluble form of the VEGF receptor (Flt-1)
- Secreted in massive excess by the syncytiotrophoblast in preeclampsia
- Acts as a "decoy receptor" - circulates freely and traps VEGF and PlGF (placental growth factor), preventing them from binding their endothelial cell-surface receptors
- sFlt-1 levels are detectable in maternal blood before the clinical syndrome appears
2. sEng (Soluble Endoglin)
- A co-receptor for TGF-β1 (transforming growth factor beta-1)
- Excess sEng circulates and traps TGF-β1, blocking its signaling
- TGF-β1 normally stimulates endothelial nitric oxide (NO) production - a potent vasodilator. Blocking it leads directly to systemic vasoconstriction
The diagram below illustrates how these two proteins together cause endothelial dysfunction:
- Healthy placenta (top): VEGF and PlGF bind endothelial Flt-1 receptors → endothelium produces anticoagulant and vasodilatory factors (prostacyclin, nitric oxide)
- Preeclamptic placenta (bottom): Excess sFlt-1 sequesters VEGF/PlGF → endothelium becomes dysfunctional → switches to pro-coagulant and vasoconstrictive state
The net result of sFlt-1 and sEng excess:
- Decreased endothelial prostacyclin (PGI₂) → vasoconstriction and platelet aggregation
- Decreased nitric oxide → systemic vasoconstriction → hypertension
- Decreased angiogenesis → defective placental vascular development (feeds back to worsen placental ischemia)
- Increased vascular permeability → proteinuria and edema
- Pro-coagulant state → thrombosis and HELLP
The full pathogenesis timeline from prepregnancy to postpartum:
(Comprehensive Clinical Nephrology 7e, Fig. 44.4 & 44.5, p. 627; Robbins, p. 954-955)
Organ-Specific Consequences of Endothelial Dysfunction
Kidney - Glomerular Endotheliosis (Hallmark Lesion)
The renal lesion of preeclampsia was first described in 1924 and termed "glomerular endotheliosis" by Spargo et al. It is considered the histological hallmark:
- Marked swelling and vacuolization of glomerular endothelial cells
- Loss of endothelial fenestrae (the openings that allow filtration)
- Fibrinogen/fibrin deposits within and under endothelial cells
- Occlusion of capillary lumina → "bloodless glomerulus" on light microscopy
- Podocyte foot processes are intact early (unlike nephrotic syndrome from other causes)
- Result: ↓ GFR, ↓ renal blood flow (due to increased afferent arteriolar resistance), proteinuria, sodium/water retention
This lesion is caused by VEGF deprivation - podocyte-specific VEGF knockout mice develop identical glomerular endotheliosis and proteinuria. Similarly, cancer patients treated with VEGF antagonists develop renal lesions identical to preeclampsia.
(Brenner and Rector's The Kidney, p. 2150)
Brain - Cerebral Edema and PRES
- Cerebral edema and petechial/parenchymal hemorrhage are hallmarks
- Edema correlates with markers of endothelial damage, not with BP severity - confirming it is endothelial dysfunction-mediated, not purely hypertensive
- MRI pattern: PRES (Posterior Reversible Encephalopathy Syndrome) - vasogenic edema predominantly in parietooccipital subcortical white matter
- Focal hypoperfusion from vasoconstriction → headaches, visual disturbances, cortical blindness, hyperreflexia, seizures
(Brenner and Rector's The Kidney, p. 2155)
Liver
- Irregular subcapsular and intraparenchymal hemorrhages
- Fibrin thrombi in portal capillaries
- Foci of hemorrhagic necrosis
- In HELLP: periportal necrosis, sinusoidal fibrin deposition → elevated transaminases
Placenta (Morphology)
- Placental hypoplasia
- Large, numerous placental infarcts
- Increased syncytial knots (ischemic change)
- Retroplacental hematomas
- Abnormal decidual vessels - fibrinoid necrosis and acute atherosis (lipid deposition in vessel intima)
Coagulation - Thrombosis and HELLP
- Reduced endothelial PGI₂ (prostacyclin - anti-thrombotic, vasodilatory)
- Increased procoagulant factor release
- Thrombosis in arterioles and capillaries throughout placenta, liver, kidneys, brain, and pituitary
- In HELLP: microangiopathic hemolysis, thrombocytopenia, transaminitis
(Robbins, Cotran & Kumar, p. 955)
Summary: The Two-Stage Model
Pre-existing risk factors
(endothelial vulnerability, genetic, immunologic, oxidative stress)
↓
Early pregnancy: Shallow trophoblast invasion
↓
Failure of spiral artery remodeling
↓
Uteroplacental ischemia / Placental hypoxia
↓
Excess sFlt-1 and sEng released from syncytiotrophoblast
↓
Sequestration of VEGF, PlGF, TGF-β1
↓
Systemic maternal endothelial dysfunction
├── ↓ Nitric oxide → Vasoconstriction → Hypertension
├── ↓ Prostacyclin → Pro-thrombotic state → HELLP
├── ↑ Vascular permeability → Proteinuria, Edema
├── Renal: Glomerular endotheliosis → AKI
├── CNS: PRES, hemorrhage, seizures
└── Hepatic: Necrosis, hemorrhage
Sources: Robbins, Cotran & Kumar - Pathologic Basis of Disease, pp. 953-956 | Comprehensive Clinical Nephrology 7e, pp. 626-628 | Brenner and Rector's The Kidney, pp. 2149-2157 | Barash Clinical Anesthesia 9e, p. 3508